INTENSITY THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Intensity Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2022 to Q3 2024.
  • Intensity Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.51M, a 50.8% decline year-over-year.
  • Intensity Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$16.3M.
  • Intensity Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$10.5M, a 39% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$16.3M -$3.51M -$1.18M -50.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$15.1M -$4.97M -$1.27M -34.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$13.8M -$4.6M -$3.27M -245% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$10.5M -$3.17M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$2.33M -$554K -31.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$3.7M -$1.77M -92% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$1.34M Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q3 2022 -$1.77M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.93M Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.